Stanford
http://www.stanfordgroup.com/#Stanford provides institutional investment services and private wealth management services. The firm also offers equity research to its clients in the consumer, media, energy, financial, healthcare, technology and water/environment sectors.
View Older Stories View More Recent Stories
-
Magenta Therapeutics (MGTA) Announces Additional Preliminary Positive Results from Ongoing Phase 2 Clinical Trial of MGTA-145 and Plerixafor in Patients with Multiple Myeloma at ASCO
-
DermTech (DMTK) Appoints Three New Scientific Advisors to its Board
-
Stanford Equipment Launches Ecommerce Website
-
Stanford Equipment Launches Ecommerce Website
-
Alpine Immune Sciences (ALPN) Appoints Zelanna Goldberg, M.D., M.A.S. as Chief Medical Officer
-
Colgate Eliminates Tuition for Families With Incomes Less Than $80,000
-
Adverum Biotechnologies (ADVM) Appoints CMO and CSO
-
Alliance Data Systems (ADS) Names Karin Kimbrough to Board
-
Stanford Libraries receives an important East Asian information technology collection
-
NRx Pharmaceuticals (NRXP) Names General H.R. McMaster to Company's Board of Directors
-
Okta, Inc. (OKTA) Welcomes Experienced Financial Executive Jeff Epstein to Board of Directors
-
California Water Service (CWT) Reports Election of Dr. Bonnie Maldonado to Board
-
Chris Womack named chairman and CEO of Georgia Power (SO)
-
Abeona Therapeutics (ABEO) Issues Letter to Stockholders
-
AptarGroup (ATR) Names Candace Matthews to Board
-
Torex Gold Announces Proposed Changes to Its Board of Directors
-
Aviat Networks (AVNW) Appoints Michele Klein to its Board of Directors
-
StoneCo (STNE) Announces New Members of the Board of Directors and the Creation of New Board Committees
-
Rocket Pharmaceuticals (RCKT) Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs at ASGCT
-
Magenta Therapeutics (MGTA) Announces Positive Preliminary Results from Phase 2 Clinical Trial of MGTA-145 in Multiple Myeloma and Provides an Update on its Anticipated Clinical Study with MGTA-117
-
Stanford University Orthopedic Study Collaboration with Endonovo Therapeutics SofPulse® Devices Moves Forward
-
Stanford University Orthopedic Study Collaboration with Endonovo Therapeutics SofPulse® Devices Moves Forward
-
Knight-Hennessy Scholars announces new scholars in its 2021 cohort representing 26 countries and 37 graduate degree programs at Stanford
-
QS USA University Rankings 2021
-
Stanford Health Care, Stanford Health Care – ValleyCare Earn As in Patient Safety During COVID-19 Surge
-
Torex Gold Thanks Retiring Long-Term Directors
-
Akebia Therapeutics (AKBA) Announces NEJM Publishes Results of Global Phase 3 Clinical Program of Vadadustat for the Treatment of Anemia Due to CKD
-
Stanford Team Finds AI to Safely Include Study Subjects Who Could Have Been Ruled Out Previously
-
Beyond Meat (BYND) Announces Brand New Beyond Burger® Launches at Grocery Stores Nationwide
-
CohBar (CWBR) Appoints Joseph J. Sarret, M.D., J.D. as Chief Executive Officer and Director
-
Clean Fuel Washington Celebrates Legislature’s Final Passage of HB 1091, A Clean Fuel Standard
-
Edifice, a Healthcare Disruptor spun out of Stanford, Raises $12 Million to Reinvent Immune Health, Improve Healthspan, and Change Course of Aging
-
LiveRamp (RAMP) Announces Omar Tawakol to Board
-
Bluelinx Holdings (BXC) Announces CEO Succession
-
TG Therapeutics (TGTX) Announces Positive Results from the ULTIMATE I & II Phase 3 Trials of Ublituximab in MS to be Presented at American Academy of Neurology 73rd Annual Meeting
-
California Water Service (CWT) Announces Nomination of Dr. Yvonne A. Maldonado for Election to Board of Directors
-
Alpine Immune Sciences (ALPN) Presents Clinical and Preclinical Oncology Program Updates at AACR Virtual Annual Meeting I
-
Beyond Meat (BYND) Announces Major Retail Expansions Throughout Europe
-
Lucira (LHDX) COVID-19 Test Kit Identifies Viral Variants
-
Beyond Meat (BYND) Expands U.S. Retail Distribution Within Multiple National and Regional Grocery Chains
-
Aemetis (AMTX) PT Raised to $35 at Stifel
-
Stanford University Leader Collaborates with former The North Face Innovation Expert on Global Textile Energy Transformation.
-
Stanford Medicine Joins Pivotal Phase 3 Clinical Trial of NOVOCART® 3D for Patients with Articular Cartilage Defects of the Knee
-
Stanford Children's Health's Pediatric Transplant Program Once Again Achieves National Recognition
-
Prothena Corp. (PRTA) Announces Appointment of Hideki Garren, MD, PhD, as CMO
-
H&R Block (HRB) Announces Mia Mends and Sean Cohan Join Board
-
IPO for Online Course Provider Coursera (COUR) Opens 18% Higher
-
MaxLinear (MXL) Appoints Tsu-Jae King Liu to Its Board of Directors
-
Marathon Digital Holdings (MARA) to Launch the First North American-Based Bitcoin Mining Pool, Fully Compliant with U.S. Regulations
-
SomaLogic to Combine with SPAC CM Life Sciences II (CMIIU)

